Hikma Pharmaceuticals (LSE:HIK)
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.
{{ formattedPrice }} {{ change }} (2.42%)
Quotes delayed. Last trade: 17-08-2018, 04:35:05pm BST
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 763485 |
Related Articles
-
Why I’d buy this FTSE 250 flyer alongside AstraZeneca plc
I reckon there is more to come for investors from this pharmaceutical company and from AstraZeneca plc (LON: AZN). Read More »
-
Why is the Burberry share price up 20% so far this year?
Shares in Burberry Group plc (LON:BRBY) are riding high as the luxury fashion house makes good progress on its turnaround. Read More »
-
2 super growth stocks I’d buy with £5,000 today
Just £5,000 could help you make a fortune with these super growth stocks. Read More »
-
2 cheap growth stocks I’d buy for the long term
These two shares could offer a mix of growth and value in current market conditions. Read More »
-
2 FTSE 250 pharma stocks I’d buy today and hold for another five years
Roland Head takes a look at two unusual pharma stocks with long-term growth potential. Read More »
-
Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA
G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys. Read More »
-
Two defensive growth stocks I’d buy and hold for 10 years
These two stocks are struggling today but the future could still be bright. Read More »
-
2 turnaround stocks I’d consider buying before 2018
Could these two turnaround stocks beat the market in 2018 and beyond? Read More »
-
Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?
Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results. Read More »
-
Why I’d buy this FTSE 250 stock alongside AstraZeneca plc
I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player. Read More »
